Ardila MCM, Solarte VAS, Guzmán ZIC

Language: Spanish
References: 16
Page: 425-431
PDF size: 760.18 Kb.

ABSTRACT

Background: treatment protocols that include the combination of mechanical periodontal and antimicrobial therapy have shown greater clinical and microbiological efficacy compared to traditional mechanical therapy.
Objective: to evaluate the influence of basal porphyromonas gingivalis on clinical parameters of patients treated with moxifloxacin attached to traditional mechanical therapy in aggressive periodontitis.
Methods: an experimental study in treatment groups in which 40 patients were distributed in equitable way. One group received mechanical therapy plus moxifloxacin 400 mg systemically administered, once daily for seven days. Also, a control group received mechanical therapy and placebo, also once daily for seven days. Patients were randomly assigned to one of two study groups. Patients were evaluated clinically and microbiologically before periodontal therapy and six months after treatment.
Results: a higher increase was observed in clinical attachment level and greater reduction in probing depth in the group treated with moxifloxacin, with statistically significant differences favoring patients with presence of p. gingivalis at baseline. Multiple linear regression analysis showed that the presence of p. gingivalis at baseline was significantly associated with improved clinical parameters six months after therapy. The interaction p. gingivalis moxifloxacin was also significantly associated with a rise in clinical attachment level and probing depth decreased.
Conclusions: adjunctive moxifloxacin compared to traditional mechanical therapy leads to improved clinical benefits in patients with aggressive periodontitis harboring p. gingivalis.

REFERENCES

1. Keestra JA, Grosjean I, Coucke W, Quirynen M, Teughels W. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis. J Pe-riodontal Res. 2015 Dec;50(6):689-706.

2. Ardila Medina CM, Martelo-Cadavid JF, Bo-derth-Acosta G, Ariza-Garcés AA, Guzmán Zuluaga IC. Adjunctive moxifloxacin in the treatment of generalized aggressive perio-dontitis patients: clinical and microbiological results of a randomized, triple-blind and pla-cebo-controlled clinical trial. J Clin Periodon-tol. 2015 Feb;42(2):160-8.

3. Guerrero A, Nibali L, Lambertenghi R, Ready D, Suvan J, Griffiths GS, et al. Impact of baseline microbiological status on clinical outcomes in generalized aggressive perio-dontitis patients treated with or without ad-junctive amoxicillin and metronidazole: an exploratory analysis from a randomized con-trolled clinical trial. J Clin Periodontol. 2014 Nov;41(11):1080-9.

4. Monteiro MF, Casati MZ, Taiete T, Vale HF do, Nociti FH Jr, Sallum EA, et al. Periodontal clinical and microbiological char-acteristics in healthy versus generalized ag-gressive periodontitis families. J Clin Perio-dontol. 2015 Oct;42(10):914-21.

5. Guzmán Zulluaga IC, Grisales Romero H, Ardila Medina CM. Administración sistémica adjunta de moxifloxacina versus ciprofoxaci-na más metronidazol en el tratamiento de periodontitis crónica con presencia de baci-los entéricos Gram negativos: II. Análisis multinivel. Rev Fac Odontol Univ Antioq. Jun 2012;23(2):207-224.

6. Eick S, Seltmann T, Pfister W. Efficacy of antibiotics to strains of periodontopathogen-ic bacteria within a single species biofilm - an in vitro study. J Clin Periodontol. 2004 May;31(5):376-83.

7. Mombelli A, Cionca N, Almaghlouth A, Dé-caillet F, Courvoisier DS, Giannopoulou C. Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomy-cetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of efficacy and safety. J Periodontol. 2013 Jun;84(6):715-24.

8. Ardila Medina CM, Guzmán Zuluaga IC. Ben-efits of adjunctive moxifloxacin in general-ized aggressive periodontitis: a subgroup analyses in Aggregatibacter actinomycetem-comitans-positive/negative patients from a clinical trial. J Investig Clin Dent [Internet]. 2015 Sep 18 [citado 2015 Abr 12]; [about 8 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/jicd.12197/pdf

9. Armitage GC. Development of a classifica-tion system for periodontal diseases and conditions. Ann Periodontol. 1999 Dec;4(1):1-6.

10. D'Ercole S, Catamo G, Tripodi D, Piccolomi-ni R. Comparison of culture methods and multiplex PCR for the detection of periodon-topathogenic bacteria in biofilm associated with severe forms of periodontitis. New Mi-crobiol. 2008 Jul;31(3):383-91.

11. Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol. 1986 Nov;1(1):48-57.

12. Varela VM, Heller D, Silva-Senem MX, Torres MC, Colombo AP, Feres-Filho EJ. Systemic antimicrobials adjunctive to a re-peated mechanical and antiseptic therapy for aggressive periodontitis: a 6-month randomized controlled trial. J Periodontol. 2011 Aug;82(8):1121-30.

13. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized ag-gressive periodontitis: a randomized, pla-cebo-controlled trial. J Clin Periodontol. 2012 Mar;39(3):284-94.

14. Tsaousoglou P, Nietzsche S, Cachovan G, Sculean A, Eick S. Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm. J Med Micro-biol. 2014 Feb;63(Pt 2):284-92

15. Guentsch A, Jentsch H, Pfister W, Hoff-mann T, Eick S. Moxifloxacin as an adjunc-tive antibiotic in the treatment of severe chronic periodontitis. J Periodontol. 2008 Oct;79(10):1894-903.

16. Haffajee AD, Patel M, Socransky SS. Micro-biological changes associated with four dif-ferent periodontal therapies for the treat-ment of chronic periodontitis. Oral Microbi-ol Immunol. 2008 Apr;23(2):148-57.